Summary
Escherichia coli strains (n=678 and n=670) isolated from faecal samples from 90 and 93 healthy volunteers of two cities, Weert and Roermond respectively, were analysed for their susceptibility to 12 antimicrobial agents during a 15-week period. Significant differences between both cities in the distribution of the MIC values were observed for apramycin, chloramphenicol, kanamycin, neomycin, nitrofurantoin, sulfamethoxazole and trimethoprim. For Weert (n=678) the antibiotic resistance percentages varied from 0.4% for nalidixic acid to 26.7% for sulfamethoxazole. For Roermond (n=670) the figures varied from 0.6% for nitrofurantoin to 37.5% for sulfamethoxazole. Resistance to amoxicillin/clavulanate was not found in either city. The most frequent pattern was resistance to sulfamethoxazole only, followed by resistance to oxytetracycline, streptomycin and sulfamethoxazole. In each individual there was only a small variation in resistance patterns of the isolates, i. e. the majority had one (n=51) or two (n=63) patterns with a maximum of five during the 15-week period. A fully susceptible pattern was found in the strains from 38 individuals.
Zusammenfassung
Stämme vonEscherichia coli, (n=678 und n=670), die aus Stuhlproben von jeweils 90 und 93 gesunden Freiwilligen aus zwei Städten, Weert und Roermond, gewonnen wurden, wurden auf ihre Empfindlichkeit gegenüber 12 antimikrobiellen Substanzen geprüft. Die Untersuchung lief über 15 Wochen. Für Apramycin, Chloramphenicol, Kanamycin, Neomycin, Nitrofurantoin, Sulfamethoxazol und Trimethoprim fanden sich zwischen den beiden Städten signifikante Unterschiede in den MHK-Werten. Für Weert (n=678) fanden sich Resistenzraten, die von 0,4% bei Nalidixinsäure bis 26,7% für Sulfamethoxazol reichten. In Roermond (n=670) variierten die Resistenzraten von 0,6% für Nitrofurantoin bis 37,5% für Sulfamethoxazol. In keiner der beiden Städte fand sich Resistenz gegenüber Amoxicillin-Clavulansäure. Als häufigstes Muster fand sich Resistenz gegen Sulfamethoxazol allein, es folgten Resistenz gegen Oxytetracyklin, Streptomycin und Sulfamethoxazol. Die intraindividuellen Resistenzmuster der Isolate variierten nur sehr wenig, das heißt, die meisten hatten Resistenz gegen ein (n=51) oder zwei (n=63) Antibiotika, maximal fünf während der 15 Wochen. Bei 38 Personen zeigten alle Stämme volle Empfindlichkeit gegen die Testsubstanzen.
Similar content being viewed by others
References
Kunin, C. M., Johansen, K. S., Worning, A. M., Daschner, F. D. Report of a symposium on use and abuse of antibiotics worldwide. Rev. Infect. Dis. 12 (1990) 12–19.
Marr, J. J., Moffet, H. L., Kunin, C. M. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the infectious diseases society of America. J. Infect. Dis. 157 (1988) 869–876.
Murray, B. E. New aspects of antimicrobial resistance and the resulting therapeutic dilemmas. J. Infect. Dis. 163 (1991) 1185–1194.
Hirai, K., Aoyama, H., Suzue, S., Irikura, T., Iyobe, S., Mitsuhashi, S. Isolation and characterization of norfloxacin-resistant mutants ofEscherichia coli K-12. Antimicrob. Agents Chemother. 30 (1986) 248–253.
Yoshida, H., Bogaki, M., Nakamura, M., Nakamura, S. Quinolone resistance-determining region in the DNA gyrase gyrA gene ofEscherichia coli. Antimicrob. Agents Chemother. 34 (1990) 1271–1272.
Gutmann, L., Kitzis, D., Billot-Klein, D., Goldstein, F., Tran Van Nhieu, G., Lu, T., Carlet, J., Collatz, E., Williamson, R. Plasmid-mediated β-Lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam. Rev. Infect. Dis. 10 (1988) 860–866.
Jacoby, G. A., Archer, G. L. New mechanisms of bacterial resistance to antimicrobial agents. N. Engl. J. Med. 324 (1991) 601–612.
Neu, H. C. The emergence of bacterial resistance and its influence on empiric therapy. Rev. Infect. Dis. 5 (Suppl.) (1983) S9-S20.
Cooksey, R., Swenson, J., Clark, N., Gay, E., Thornsberry, C. Patterns and mechanisms of β-lactam resistance among isolates ofEscherichia coli from hospitals in the United States. Antimicrob. Agents Chemother. 34 (1990) 739–745.
Datta, N., Dacey, S., Hughes, V., Knight, S., Richards, H., Williams, G., Casewell, M., Shannon, K. Distribution of genes for trimethoprim and gentamicin resistance in bacteria and their plasmids in a general hospital. J. Gen. Microbiol. 118 (1980) 495–508.
Fisher, G. M., Kelsey, M. C., Cooke, E. M. An investigation of the spread of gentamicin resistance in a district general hospital. J. Med. Microbiol. 22 (1986) 69–77.
Mayer, K. H., Fling, M. E., Hopkins, J. D., O'Brien, T. F. Trimethoprim resistance in multiple genera ofEnterobacteriaceae at a U.S. hospital: spread of the type II dihydrofolate reductase gene by a single plasmid. J. Infect. Dis. 151 (1985) 783–790.
Møller, J. K., Bak, A. L., Bülow, P., Christiansen, C., Christiansen, G., Stenderup, A. Transferable and non-transferable drug resistance in enteric bacteria from hospital and from general practice. Scand. J. Infect. Dis. 8 (1976) 112–116.
Seetulsingh, P. S., Hall, L. M. C., Livermore, D. M. Activity of clavulanate combinations against TEM-1 β-lactamase-producingEscherichia coli isolates obtained in 1982 and 1989. J. Antimicrob. Chemother. 27 (1991) 749–759.
Brumfitt, W., Reeves, D. S., Faiers, M. C., Datta, N. Antibiotic-resistantEscherichia coli causing urinary-tract infection in general practice: relation to faecal flora. Lancet i (1971) 315–317.
Gillespie, W. A., Lee, P. A., Linton, K. B. Antibiotic resistance of coliform bacilli in urinary infection acquired by women outside hospital. Lancet ii (1971) 675–677.
Towner, K. J., Wise, P. J. Transferable resistance plasmids as a contributory cause of increasing trimethoprim resistance in general practice. J. Antimicrob. Chemother. 11 (1983) 33–39.
Bonten, M., Stobberingh, E., Philips, J., Houben, A. Antibiotic resistance ofEscherichia coli in faecal samples of healthy people in two different areas in an industrialised country. Infection 20 (1992) 258–262.
Linton, K. B., Lee, P. A., Richmond, M. H., Gillespie, W. A. Antibiotic resistance and transmissible R-factors in the intestinal coliform flora of healthy adults and children in an urban and a rural community. J. Hygiene 70 (1972) 99–104.
Hawkey, P. M. Resistant bacteria in the normal human flora. J. Antimicrob. Chemother. 18 (Suppl. C) (1986) 133–139.
Degener, J. E., Michel, M. F., Valkenburg, H. A., Smit, A. C., Muller, L., Thonus, I. P. Bacterial drug resistance in the community and in hospitals. Neth. J. Med. 28 (1985) 182–191.
Lester, S. C., Pla del Pilar, M., Wang, F., Perez Schael, I., Jiang, H., O'Brien, T. F. The carriage ofEscherichia coli resistant to antimicrobial agents by healthy children in Boston, in Caracas, Venezuela, and in Qin Pu, China. N. Engl. J. Med. 323 (1990) 285–289.
London, N., Nijsten, R., van den Bogaard, A., Stobberingh, E. Antibiotic resistance of faecalEnterobacteriaceae isolated from healthy volunteers, a 15-week follow-up study. J. Antimicrob. Chemother. 32 (1993) 83–91.
van Klingeren, B., Mouton, R. P. Standaardisatie van gevoeligheids-bepalingen. Verslag van de werkgroep richtlijnen gevoeligheidsbepalingen. Rijksinstituut voor Volksgezondheid en Milieuhygiene, Bilthoven, The Netherlands 1990.
Hunter, J., Shelley, J. C., Walton, J. R., Hart, C. A., Bennett, M. Apramycin resistance plasmids inEscherichia coli: possible transfer toSalmonella typhimurium in calves. Epidemiol. Infect. 108 (1992) 271–278.
Sambrook, J., Fritsch, E. F., Maniatis, T. Molecular cloning: a laboratory manual. 2nd edition. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 1989.
Sundström, L., Rådström, P., Swedberg, G., Sköld, O. Site-specific recombination promotes linkage between trimethoprim and sulfonamide resistance genes. Sequence characterization ofdhfrV andsulI and a recombination active locus of Tn21. Mol. Gen. Genet. 213 (1988) 191–201.
Sundström, L., Sköld, O. ThedhfrI trimethoprim resistance gene of Tn7 can be found at specific sites in other genetic surroundings. Antimicrob. Agents Chemother. 34 (1990) 642–650.
Levy, S. B., Marshall, B., Schluederberg, S., Rowse, D., Davis, J. High frequency of antimicrobial resistance in human fecal flora. Antimicrob. Agents Chemother. 32 (1988) 1801–1806.
Cohen, S. P., McMurry, L. M., Hooper, D. C., Wolfson, J. S., Levy, S. B. Cross-resistance to fluoroquinolones in multiple antibiotic-resistant (Mar)Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition toOmpF reduction. Antimicrob. Agents Chemother. 33 (1989) 1318–1325.
Hächler, H., Cohen, S. P., Levy, S. B. marA, a regulated locus which controls expression of chromosomal multiple antibiotic resistance inEscherichia coli. J. Bacteriol. 173 (1991) 5532–5538.
Chaslus-Dancla, E., Glupczynski, Y., Gerbaud, G., Lagorce, M., Lafont, J. P., Courvalin, P. Detection of apramycin resistantEnterobacteriaceae in hospital isolates. FEMS Microbiol. Lett. 61 (1989) 261–266.
Chaslus-Dancla, E., Pohl, P., Meurisse, M., Marin, M., Lafont, J. P. High genetic homology between plasmids of human and animal origins conferring resistance to the aminoglycosides gentamicin and apramycin. Antimicrob. Agents Chemother. 35 (1991) 590–593.
Singh, K. V., Reves, R. R., Pickering, L. K., Murray, B. E. Identification by DNA sequence analysis of a new plasmid-encoded trimethoprim resistance gene in fecalEscherichia coli isolates from children in day-care centers. Antimicrob. Agents Chemother. 36 (1992) 1720–1726.
Møller, J. K. A microcomputer assisted analysis of drug resistance in bacteria. Comput. Methods Programs Biomed. 23 (1986) 217–223.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
London, N., Nijsten, R., Bogaard, A.v.d. et al. Carriage of antibiotic-resistantEscherichia coli by healthy volunteers during a 15-week period. Infection 22, 187–192 (1994). https://doi.org/10.1007/BF01716700
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01716700